文献速递介入腹部CTDSA

肝脏动脉介入中Angio-CT不增加患者辐射暴露

Angio-CT does not increase patient radiation exposure compared to conventional cone-beam CT for intra-arterial liver procedures.
PubMed 文献 · Eur Radiol · 2026-10-02

结果显示Angio-CT组3D有效剂量中位数显著降低(9.85 mSv vs 39.9 mSv),但总有效剂量在不确定性校正后差异不显著(校正P=0.053)。结论认为双期Angio-CT不增加总体辐射暴露。

要点

  • 肝脏动脉介入中,双期Angio-CT的3D有效剂量较单期CBCT低4.1倍。
  • 总有效剂量在不确定性校正后差异不显著,整体辐射暴露未增加。
  • 在具备条件时,可优先选用Angio-CT以获取更优图像质量而不增加辐射风险。

局限性

  • 回顾性研究设计。
  • 总有效剂量在不确定性校正后差异不显著,需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate patient radiation dose during intra-arterial liver procedures using Computed Tomography angiography (angio-CT) compared with C-arm Cone-Beam CT (CBCT).

MATERIAL AND METHODS: This retrospective study included bland embolization and radioembolization mapping procedures performed between November 2021 and December 2024 using dual-phase angio-CT or single-phase CBCT on a hybrid angiography suite. Effective dose was calculated by converting dose-area and dose-length product using conversion factors. Fluoroscopy-only (2D), CBCT/angio-CT (3D) effective dose and total effective dose were compared using the Mann-Whitney U-test. Bootstrap resampling and permutation testing with Monte Carlo error propagation were applied to assess the robustness of 3D and total effective dose comparisons.

RESULTS: Ninety-two procedures were included: 48 in the CBCT group and 44 in the angio-CT group. The 2D effective dose was comparable. The 3D effective dose was 4.1-fold lower in the angio-CT group (median 9.85 [IQR: 5.37-22.6 mSv] vs 39.9 mSv [IQR: 21.2-69.6 mSv], p < 0.001), resulting in 1.6-fold reduction in total effective dose for procedures performed by angio-CT (median 34.6 [IQR: 23.7-54.3 mSv] vs 55.9 mSv [IQR: 37.6-103 mSv], p < 0.001). After dose conversion uncertainty correction, corrected p-values were < 0.001 for 3D effective dose and 0.053 for the total dose.

CONCLUSION: Hybrid angiography suites incorporating angio-CT significantly reduced 3D effective dose compared to single-phase CBCT imaging. However, the total effective dose did not remain significant after uncertainty correction. Therefore, the use of angiography suites incorporating dual-phase angio-CT does not appear to change patient radiation exposure during intra-arterial liver procedures.

KEY POINTS: Question What is the effect of integrating angio-CT into hybrid angiography suites on patient radiation exposure? Findings Dual-phase angio-CT integration into intra-arterial liver therapy workflows does not increase overall procedural radiation exposure and is associated with a decreased 3D effective dose. Clinical relevance Angio-CT offers several clinical advantages, and existing literature demonstrates improved image quality compared with CBCT. This study shows that dual-phase angio-CT does not increase patient radiation exposure compared to single-phase CBCT, supporting its use when available.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Schneider C, Keijzers H, Rijkhorst EJ, et al. Angio-CT does not increase patient radiation exposure compared to conventional cone-beam CT for intra-arterial liver procedures. Eur Radiol. 2026. PMID: 42823562. doi:10.1007/s00330-026-12906-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。